希腊阿博托毒素A的成本效益和预算影响分析
Nikolaos Nomikos1, Christos Eleftheriou2, Kostas Athanasakis1
1Laboratory for Health Technology Assessment, Department of Public Health Policy, School of Public Health, University of West Attica, 11521 Athens, Greece.
Toxins
|September 27, 2023
概括
阿博丁毒素A (aboBoNT-A) 加上最佳支持性护理 (BSC) 是希腊肢体的经济有效治疗方法. 引入aboBoNT-A与onaBoNT-A (onaBoNT-A) 相比,可以节省医疗保健费用.
科学领域:
- 卫生经济学 卫生经济学
- 药物经济学 药物经济学
- 神经学 神经学
背景情况:
- 肢体性严重影响成年患者的生活质量.
- 在医疗保健系统中,对四肢的有效和经济的管理策略至关重要.
研究的目的:
- 为了评估abobotulinumtoxinA (aboBoNT-A) 加上最佳支持性护理 (BSC) 与单独用于希腊成年四肢的BSC的成本效益.
- 在希腊医疗保健系统中进行aboBoNT-A与onaBoNT-A相比引入aboBoNT-A的预算影响分析.
主要方法:
- 利用临床研究数据来评估药物的疗效和患者的效用.
- 从希腊医疗保健来源收集成本数据.
- 进行了成本效益和预算影响分析.
主要成果:
- 亚博丁毒素A (aboBoNT-A) 加上BSC在上肢和下肢性方面表现出具有成本效益.
- 预计aboBoNT-A的引入将在希腊五年内节省制药成本.
- 亚博毒素A (aboBoNT-A) 是一个比亚博毒素A (onaBoNT-A) 更经济的替代品.
结论:
- 阿博托毒素A (aboBoNT-A) 加BSC是希腊成年肢体的经济有效治疗方法.
- 纳入aboBoNT-A可能会提高患者获取和医疗保健资源效率.
- 在希腊医疗保健系统中,阿博胺毒素A (aboBoNT-A) 与阿博胺毒素A (onaBoNT-A) 相比,提供了更经济的选择.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
698
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
698
Skeletal Muscle Relaxants: Therapeutic Uses
506
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
506
Depolarizing Blockers: Pharmocokinetics
347
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
347
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
450
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
450
Skeletal Muscle Relaxants: Adverse Effects
393
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
393


